Mylotarg (Gemtuzumab ozogamicin)
gemtuzumab ozogamicin 5 mg injection, 1 vial · INJECTION · PBS code 12844B
AUTHORITY_REQUIREDWhat it costs
AU$9167 PBS-determined price per pack
Most patients pay only the standard PBS co-payment, not the full price above — up to AU$25.00 per script (general) or AU$7.70 (concession/Safety Net) in 2026. The figure above is what the PBS pays the pharmacy; the Australian Government subsidises the rest. Always confirm the current amount with your pharmacist.
- • First listed on the PBS: 2022-03-01.
- • Repeats: 2.
- • PBS program: IP.
Eligibility criteria for subsidised access
The following is the government's own wording from the PBS Schedule, shown unchanged.
Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1
Acute Myeloid Leukaemia
Induction treatment
Patient must have confirmed CD33-positive AML prior to initiation of treatment; AND
The condition must be de novo; AND
The condition must be previously untreated at the time of initiation (except for prior essential treatment with hydroxyurea or leukapheresis for patients with hyperleukocytic AML); AND
Patient must have confirmed intermediate/favourable cytogenetic risk; or
Patient must have unknown cytogenetic risk due to inconclusive test results; AND
Patient must have a World Health Organisation (WHO) Eastern Cooperative Oncology Group (ECOG) performance status score of 2 or less; AND
The condition must not be acute promyelocytic leukaemia; AND
The treatment must be in combination with standard intensive remission induction chemotherapy for this condition, which must include cytarabine and an anthracycline; AND
The treatment must not be used in combination with a tyrosine kinase inhibitor; AND
The condition must not be internal tandem duplication (ITD) or tyrosine kinase domain (TKD) FMS tyrosine kinase 3 (FLT3) mutation positive; AND
Patient must not receive more than 1 induction cycle under this restriction in a lifetime.
This drug is not PBS-subsidised if it is prescribed to an in-patient in a public hospital setting.
Sponsor: Pfizer Australia Pty Ltd ABN 50 008 422 348
Not medical advice. Voxsanity republishes public PBS data in plain English. PBS listing status and criteria can change; always confirm current subsidised availability with your doctor or pharmacist.
Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.